Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000544942 | SCV000633311 | likely benign | Familial cancer of breast | 2023-08-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000575984 | SCV000666889 | likely benign | Hereditary cancer-predisposing syndrome | 2016-10-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000575984 | SCV000690816 | likely benign | Hereditary cancer-predisposing syndrome | 2016-04-26 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000544942 | SCV000786336 | likely benign | Familial cancer of breast | 2018-04-09 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002497105 | SCV002808861 | likely benign | Familial cancer of breast; Fanconi anemia complementation group N; Pancreatic cancer, susceptibility to, 3 | 2022-03-30 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000544942 | SCV004019183 | benign | Familial cancer of breast | 2023-03-30 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |